Abstract:Adrenomedullin (ADM) and proadrenomedullin N-terminal 20 peptide (PAMP) are widely distributed in various body tissues and organs, including the hypothalamo-pituitary-adrenal (HPA) axis. ADM and PAMP inhibit in vitro release of ACTH from pituitary corticotropes, and findings suggest that this effect may become relevant when an exceedingly high ACTH secretion must be counteracted. ADM directly supresses angiotensin-II- and K+-stimulated aldosterone secretion from ZG cells, acting through calcitonin gene-related peptide (CGRP) type 1 ADM(22-52)-sensitive receptors, the activation of which is likely to impair Ca2+ influx. In contrast, ADM stimulates medullary chromaffin cells to release catecholamines, which in turn enhance aldosterone secretion acting in a paracrine manner. Also this effect of ADM occurs via CGRP1 receptors, which are coupled with the adenylate cyclase-dependent cascade. There is indication that in vivo these two opposite effects of ADM on ZG may interact with each other when normal aldosterone secretion has to be restored. ADM exerts a mitogenic effect on rat ZG, acting via CGRP1 receptors that activate the tyrosine kinase-dependent mitogen-activated protein kinase cascade. These findings, along with the demonstration of a high level of ADM gene expression in adrenocortical adenomas and carcinomas, may suggest a role for ADM as adrenocortical growth stimulator and tumor promoter. PAMP, like ADM, suppresses aldosterone response of ZG cells to Ca2+-dependent agonists, but, in contrast with ADM, it inhibits catecholamine release by adrenal medulla. Both effects of PAMP are mediated by PAMP(12-20)-sensitive receptors, whose signaling mechanism is likely to involve the blockade of voltage-gated Ca2+ channels. The concentrations attained by ADM and PAMP in the blood rule out the possibility that they act as true circulating hormones. Conversely, their content in the hypothalamo-pituitary complex and adrenal gland is consistent with a paracrine mechanism of action, which may play an important role in pathophysiological conditions where the function of the HPA axis has to be reset.

Adiponectin Regulates ACTH Secretion and the HPAA in an AMPK-dependent Manner in Pituitary Corticotroph Cells

Expression of adiponectin receptors in mouse adrenal glands and the adrenocortical Y-1 cell line: adiponectin regulates steroidogenesis.

Proadrenomedullin-derived peptides in the paracrine control of the hypothalamo-pituitary-adrenal axis

Gnrh Secretion is Inhibited by Adiponectin Through Activation of Amp-Activated Protein Kinase and Extracellular Signal-Regulated Kinase

Adrenocorticotropic hormone ameliorates acute kidney injury by steroidogenic-dependent and -independent mechanisms.

Adiponectin modulates carnitine palmitoyltransferase-1 through AMPK signaling cascade in rat cardiomyocytes.

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

Differential Modulation of Catecholamine and Adipokine Secretion by the Short Chain Fatty Acid Receptor FFAR3 and α2-Adrenergic Receptors in PC12 Cells

Signal channel research on aldosterone and cortisol secretion in H295R cells after adrenocorticotropin stimulation

Mimecan in Pituitary Corticotroph Cells May Regulate Acth Secretion and the Hpaa

Preliminary studies on the differential expression of adrenocorticotropic hormone receptor in adrenal adenomas.

Adiponectin Receptor Agonist AdipoRon Suppresses Adipogenesis in C3H10T1/2 Cells Through the Adenosine Monophosphate-Activated Protein Kinase Signaling Pathway

Ursolic Acid Suppresses Growth and Adrenocorticotrophic Hormone Secretion in AtT20 Cells As a Potential Agent Targeting Adrenocorticotrophic Hormone-Producing Pituitary Adenoma

Adiponectin Inhibits GnRH Secretion Via Activating AMPK and PI3K Signaling Pathways in Chicken Hypothalamic Neuron Cells.

Adiponectin protects against angiotensin Ⅱ—induced atrial myocyte hypertrophy through AMP-activated protein kinase

Globular Adiponectin Inhibits GnRH Secretion from GT1-7 Hypothalamic GnRH Neurons by Induction of Hyperpolarization of Membrane Potential.

Adiponectin Sensitizes Insulin Signaling by Reducing p70 S6 Kinase-mediated Serine Phosphorylation of IRS-1

Effect of Adrenocorticotrophic Hormone (ACTH) on Serum Lipids Metablish in a Hyperlipidemic Rabbit Model

Adiponectin Potentiates the Acute Effects of Leptin in Arcuate Pomc Neurons

Adipose tissue regulates hepatic cholesterol metabolism via adiponectin

Adiponectin Protects Leydig Cells Against Proinflammatory Cytokines by Suppressing the Nuclear Factor‐κb Signaling Pathway